Skip to main content
. 2025 May 22;43(19):2155–2163. doi: 10.1200/JCO.24.00905

TABLE 2.

Ear Pain and Tinnitus Treatment-Emergent Adverse Events by Treatment

Preferred Term Placebo (N = 22), No. (%) DB-020 12% (n = 11), No. (%) DB-020 25% (n = 11), No. (%) DB-020 (N = 22), No. (%)
Ear pain 3 (14) 8 (73) 9 (82) 17 (77)
Tinnitus 11 (50) 0 (0) 3 (27) 3 (14)